Sintx Technologies (SINT) Competitors $3.05 -0.03 (-0.97%) Closing price 08/14/2025 04:00 PM EasternExtended Trading$2.92 -0.13 (-4.10%) As of 08/14/2025 06:26 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock SINT vs. FEMY, VVOS, DRIO, RVP, PETV, IRIX, NXGL, ALUR, NRXS, and NXLShould you be buying Sintx Technologies stock or one of its competitors? The main competitors of Sintx Technologies include Femasys (FEMY), Vivos Therapeutics (VVOS), DarioHealth (DRIO), Retractable Technologies (RVP), PetVivo (PETV), IRIDEX (IRIX), NexGel (NXGL), Allurion Technologies (ALUR), NeurAxis (NRXS), and Nexalin Technology (NXL). These companies are all part of the "medical equipment" industry. Sintx Technologies vs. Its Competitors Femasys Vivos Therapeutics DarioHealth Retractable Technologies PetVivo IRIDEX NexGel Allurion Technologies NeurAxis Nexalin Technology Femasys (NASDAQ:FEMY) and Sintx Technologies (NASDAQ:SINT) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their media sentiment, valuation, analyst recommendations, profitability, risk, earnings, dividends and institutional ownership. Does the media refer more to FEMY or SINT? In the previous week, Femasys had 7 more articles in the media than Sintx Technologies. MarketBeat recorded 11 mentions for Femasys and 4 mentions for Sintx Technologies. Sintx Technologies' average media sentiment score of 0.96 beat Femasys' score of 0.23 indicating that Sintx Technologies is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Femasys 0 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral Sintx Technologies 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Do analysts recommend FEMY or SINT? Femasys currently has a consensus price target of $7.33, suggesting a potential upside of 887.79%. Sintx Technologies has a consensus price target of $28.00, suggesting a potential upside of 818.03%. Given Femasys' higher possible upside, equities research analysts clearly believe Femasys is more favorable than Sintx Technologies.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Femasys 0 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 3.00Sintx Technologies 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 Which has more risk and volatility, FEMY or SINT? Femasys has a beta of -2.58, meaning that its share price is 358% less volatile than the S&P 500. Comparatively, Sintx Technologies has a beta of 0.65, meaning that its share price is 35% less volatile than the S&P 500. Is FEMY or SINT more profitable? Sintx Technologies has a net margin of -483.85% compared to Femasys' net margin of -1,113.72%. Sintx Technologies' return on equity of -203.66% beat Femasys' return on equity.Company Net Margins Return on Equity Return on Assets Femasys-1,113.72% -713.74% -152.60% Sintx Technologies -483.85%-203.66%-104.76% Do insiders and institutionals hold more shares of FEMY or SINT? 65.3% of Femasys shares are owned by institutional investors. Comparatively, 18.4% of Sintx Technologies shares are owned by institutional investors. 11.5% of Femasys shares are owned by company insiders. Comparatively, 4.1% of Sintx Technologies shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth. Which has higher earnings and valuation, FEMY or SINT? Sintx Technologies has higher revenue and earnings than Femasys. Femasys is trading at a lower price-to-earnings ratio than Sintx Technologies, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioFemasys$1.63M14.84-$18.82M-$0.86-0.86Sintx Technologies$2.89M2.91-$11.02M-$50.56-0.06 SummarySintx Technologies beats Femasys on 8 of the 15 factors compared between the two stocks. Get Sintx Technologies News Delivered to You Automatically Sign up to receive the latest news and ratings for SINT and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding SINT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SINT vs. The Competition Export to ExcelMetricSintx TechnologiesMED INSTRUMENTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$8.49M$7.00B$5.61B$9.84BDividend YieldN/A1.30%4.61%4.07%P/E Ratio-0.0625.4830.2925.74Price / Sales2.9173.48470.61115.79Price / CashN/A21.9738.2159.48Price / Book1.055.388.866.15Net Income-$11.02M$176.29M$3.25B$265.06M7 Day Performance5.54%3.21%3.72%2.60%1 Month Performance9.71%1.49%5.86%2.83%1 Year Performance-27.90%10.20%30.49%25.58% Sintx Technologies Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SINTSintx Technologies3.0879 of 5 stars$3.05-1.0%$28.00+818.0%-27.6%$8.49M$2.89M-0.0640Earnings ReportShort Interest ↓FEMYFemasys2.964 of 5 stars$0.78-13.2%$7.33+845.7%-30.0%$29.04M$1.63M-0.9030Earnings ReportShort Interest ↑Analyst RevisionGap UpVVOSVivos Therapeutics0.8711 of 5 stars$4.58+4.1%$4.82+5.2%+94.5%$25.91M$15.03M-2.65160News CoverageGap DownDRIODarioHealth1.4778 of 5 stars$0.50-6.8%$2.00+297.6%-51.6%$24.57M$27.04M-0.90200News CoverageGap DownRVPRetractable Technologies1.9945 of 5 stars$0.82+5.3%N/A-26.2%$24.43M$33.75M-1.51240News CoverageShort Interest ↑Gap UpPETVPetVivoN/A$0.86-1.1%N/A+39.5%$23.68M$1.05M-1.9120News CoverageIRIXIRIDEX1.2723 of 5 stars$1.26-3.1%N/A-40.7%$21.83M$48.67M-2.93120Earnings ReportNXGLNexGel1.4041 of 5 stars$2.65-1.5%N/A-21.5%$20.59M$8.69M-5.8910News CoverageEarnings ReportUpcoming EarningsShort Interest ↓ALURAllurion Technologies2.6283 of 5 stars$2.62-2.2%$22.83+771.5%-85.9%$19.99M$32.11M-0.21501News CoverageShort Interest ↓Analyst RevisionGap DownNRXSNeurAxis2.8559 of 5 stars$2.43-1.2%$7.00+188.1%-24.7%$17.54M$2.93M-1.3219Short Interest ↑NXLNexalin Technology3.1261 of 5 stars$0.89-1.1%$5.00+461.8%-18.2%$15.68M$170K-1.173Short Interest ↓Gap Up Related Companies and Tools Related Companies FEMY Alternatives VVOS Alternatives DRIO Alternatives RVP Alternatives PETV Alternatives IRIX Alternatives NXGL Alternatives ALUR Alternatives NRXS Alternatives NXL Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:SINT) was last updated on 8/15/2025 by MarketBeat.com Staff From Our PartnersTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sintx Technologies, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Sintx Technologies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access